You are here
- Home
- Therapy Areas
- Neuroscience
An epidemiological registry study to evaluate clinical practice treatment in patients with Bipolar Disorder treated with quetiapine XR and/or quetiapine IR
- Drug Name
- Seroquel, Seroquel XR
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- Other
- Start Date
- Jan 18, 1971
- Study Name
- REED
- Study Id
- VD-NS-1101
- ClinicalTrials.gov ID
- NCT01455961
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Apr 17, 2013
- VD-NS-1101.pdf (254 KB)
